FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Adjusts Price Target on AbbVie to $278 From $270

By

AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Price: $213.21, Change: $+9.32, Percent Change: +4.57%

Related Articles